{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T08:47:58Z","timestamp":1783759678039,"version":"3.55.0"},"reference-count":43,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T00:00:00Z","timestamp":1607299200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000589","name":"Chief Scientist Office","doi-asserted-by":"publisher","award":["HIPS\/18\/49"],"award-info":[{"award-number":["HIPS\/18\/49"]}],"id":[{"id":"10.13039\/501100000589","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Viral Hepatitis"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The ease of direct\u2010acting antiviral (DAA) medications for hepatitis C virus (HCV) has provided an opportunity to decentralize HCV treatment into community settings. However, the role of non\u2010specialist clinicians in community\u2010based pathways has received scant attention to date. This study examined barriers and enablers to expanding the role of general practitioners (GPs) in HCV treatment provision, using simple behaviour change theory as a conceptual framework. A maximum variation sample of 22 HCV treatment providers, GPs and HCV support workers participated in semi\u2010structured interviews. Data were inductively coded, and the resulting codes deductively mapped into three principal components of behaviour change: capability, opportunity and motivation (COM\u2010B). By this process, a number of provider\u2010 and systemic\u2010level barriers and enablers were identified. Key barriers included the pre\u2010treatment assessment of liver fibrosis, GP capacity and the \u2018speciality\u2019 of HCV care. Enablers included the simplicity of the drugs, existing GP\/patient relationships and the provision of holistic care. In addition to these specific factors, the data also exposed an overarching provider understanding of \u2018HCV treatment\u2019 as triumvirate in nature, incorporating the assessment of liver fibrosis, the provision of holistic support and the treatment of disease. This understanding imposes a further fundamental barrier to GP\u2010led treatment as each of these three components needs to be individually addressed. To enable sustainable models of HCV treatment provision by GPs, a pragmatic re\u2010examination of the \u2018HCV treatment triumvirate\u2019 is required, and a paradigm shift from the \u2018refer and treat\u2019 status quo.<\/jats:p>","DOI":"10.1111\/jvh.13443","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T20:43:39Z","timestamp":1605905019000},"page":"528-537","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Provider\u2010related barriers and enablers to the provision of hepatitis C treatment by general practitioners in Scotland: A behaviour change analysis"],"prefix":"10.1111","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9589-8893","authenticated-orcid":false,"given":"David","family":"Whiteley","sequence":"first","affiliation":[{"name":"School of Health and Social Care Edinburgh Napier University Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4405-0670","authenticated-orcid":false,"given":"Elizabeth","family":"Speakman","sequence":"additional","affiliation":[{"name":"School of Health and Social Care Edinburgh Napier University Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7727-231X","authenticated-orcid":false,"given":"Lawrie","family":"Elliott","sequence":"additional","affiliation":[{"name":"Department of Nursing and Community Health School of Health and Life Sciences Glasgow Caledonian University Glasgow UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Davidson","sequence":"additional","affiliation":[{"name":"Department of Pharmacy NHS Lothian Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Hamilton","sequence":"additional","affiliation":[{"name":"Scottish Drugs Forum Glasgow UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5039-0228","authenticated-orcid":false,"given":"Helen","family":"Jarvis","sequence":"additional","affiliation":[{"name":"Population and Health Sciences Institute Newcastle University Newcastle UK"},{"name":"West Road Medical Centre Newcastle UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Quinn","sequence":"additional","affiliation":[{"name":"Craigmillar Medical Group Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6239-5616","authenticated-orcid":false,"given":"Paul","family":"Flowers","sequence":"additional","affiliation":[{"name":"School of Psychological Sciences and Health University of Strathclyde Glasgow UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,12,7]]},"reference":[{"key":"e_1_2_11_2_1","unstructured":"Health Protection Scotland. Scotland\u2019s Hepatitis C Action Plan: Achievements of the First Decade and Proposals for a Scottish Government Strategy (2019) for the Elimination of both Infection and Disease: Taking Advantage of Outstanding New Therapies.https:\/\/hpspubsrepo.blob.core.windows.net\/hps\u2010website\/nss\/2840\/documents\/1_hcv\u2010elimination\u2010Scotland\u2010v2.pdf. Accessed April 2 2020."},{"key":"e_1_2_11_3_1","unstructured":"World Health Organisation.Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection July 2018.https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/273174\/9789241550345\u2010eng.pdf?ua=1. Accessed April 8 2020"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2019.12.007"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-019-4635-7"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz546"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.102633"},{"key":"e_1_2_11_8_1","unstructured":"Public Health England.Hepatitis C in the UK 2019. Working to eliminate hepatitis C as a major public health threat.https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/831155\/Hepatitis_C_in_the_UK_2019_report.pdf. Accessed September 15 2020."},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-029538"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-016-4301-4"},{"key":"e_1_2_11_11_1","unstructured":"Healthcare Improvement Scotland.Area drug and therapeutics committee collaborative (ADTC Collaborative).http:\/\/www.healthcareimprovementscotland.org\/our_work\/technologies_and_medicines\/adtc_collaborative.aspx. Accessed September 22 2020."},{"key":"e_1_2_11_12_1","unstructured":"NHS Greater Glasgow and Clyde Area Drug and Therapeutics Committee.Greater glasgow and clyde prescribing: antiviral drugs.http:\/\/www.ggcprescribing.org.uk\/formulary\/infections\/antiviral\u2010drugs\/. Accessed September 22 2020."},{"key":"e_1_2_11_13_1","unstructured":"British Medical Association.Prescribing in general practice: April 2018.https:\/\/www.bma.org.uk\/media\/1563\/bma\u2010prescribing\u2010in\u2010general\u2010practice\u2010april\u20102018.pdf. Accessed September 22 2020."},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmp030"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.5604\/01.3001.0010.2757"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12910"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.7326\/M17-0118"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-017-0605-9"},{"key":"e_1_2_11_19_1","first-page":"329","volume-title":"The Behaviour Change Wheel: A Guide to Designing Interventions","author":"Michie S","year":"2014"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-6-42"},{"key":"e_1_2_11_21_1","unstructured":"Health Protection Scotland.Surveillance report: Surveillance of hepatitis C testing diagnosis and treatment in Scotland 2019 update.https:\/\/hpspubsrepo.blob.core.windows.net\/hps\u2010website\/nss\/2834\/documents\/1_hcv\u2010testing\u2010diagnosis\u2010treatment\u2010scotland\u20102018.pdf. Accessed April 16 2020."},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10488-013-0528-y"},{"key":"e_1_2_11_23_1","unstructured":"Scottish Government.Scottish index of multiple deprivation 2020.https:\/\/www.gov.scot\/collections\/scottish\u2010index\u2010of\u2010multiple\u2010deprivation\u20102020\/. Accessed September 15 2020."},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1191\/1478088706qp063oa"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v44i78a03"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp20X708785"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m322"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2018.1485699"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-3748-2"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102766"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2055-6640(20)30254-5"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-018-9902-x"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10900-020-00794-z"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13259"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.107705"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32320-7"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2016.09.017"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2018.12.010"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15780"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.03.015"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1071\/AH18220"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102714"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108025"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-019-1300-2"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvh.13443","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jvh.13443","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvh.13443","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T15:55:21Z","timestamp":1693583721000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jvh.13443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,7]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.1111\/jvh.13443"],"URL":"https:\/\/doi.org\/10.1111\/jvh.13443","archive":["Portico"],"relation":{},"ISSN":["1352-0504","1365-2893"],"issn-type":[{"value":"1352-0504","type":"print"},{"value":"1365-2893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,7]]},"assertion":[{"value":"2020-07-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}